For instance, approaches utilizing cold atmospheric plasma to restore sensitivity to chemotherapy in MGMT-expressing tumor cells have shown promise, indicating a potential avenue for enhancing treatment efficacy [49]. This evidence concerns the gene MGMT and neoplasm.